Document Detail


Rational strategy for rubella vaccination.
MedLine Citation:
PMID:  6129376     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Current rubella vaccination programmes, devised when knowledge of vaccine characteristics was still incomplete, have not been fully successful in protecting those at maximum risk of the sequelae of rubella infection. Now that more is known of vaccine characteristics and the impact of the initially chosen strategies has been assessed, it is time to modify immunisation strategies, the priorities being first to protect women of childbearing age, and then to interrupt transmission of rubella.
Authors:
A R Hinman; K J Bart; W A Orenstein; S R Preblud
Related Documents :
8341776 - An epidemiologic investigation of a rubella outbreak among the amish of northeastern ohio.
12048476 - Mmr and autism: an overview of the debate to date.
10682116 - Response to early measles-mumps-rubella vaccination in infants with chronic renal failu...
15575416 - Immunizations, immunology, and autism.
20478086 - Study on the effect of measles control programmes on periodic structures of disease epi...
24256996 - Braess's paradox in epidemic game: better condition results in less payoff.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Lancet     Volume:  1     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1983 Jan 
Date Detail:
Created Date:  1983-02-14     Completed Date:  1983-02-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  39-40     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Arthritis / etiology
Female
Great Britain
Humans
Infant, Newborn
Methods
National Health Programs*
Pregnancy
Rubella / congenital,  prevention & control*,  transmission
Rubella Vaccine* / adverse effects,  therapeutic use
United States
Vaccination*
Chemical
Reg. No./Substance:
0/Rubella Vaccine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relation between metaplastic polyp and carcinoma of the colorectum.
Next Document:  Successful substitution of rectal metronidazole administration for intravenous use.